These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 4075322

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
    Bazarbashi S, Abdelsalam M, Amin T, El-Bassiouni M, Soudy H, Elweshi A, Alhusseiny H, Rehman K, Memon M, Ajarim D.
    Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus.
    Kumar S, Dimri K, Khurana R, Rastogi N, Das KJ, Lal P.
    Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Advances in chemotherapy of esophageal cancer.
    Kelsen DP.
    Clin Bull; 1981 May; 11(3):131-8. PubMed ID: 6175446
    [No Abstract] [Full Text] [Related]

  • 15. [Histological effect and prognosis after preoperative chemotherapy in esophageal cancer].
    Ohara M, Ishihara K, Abe T, Yamazaki S, Miura T, Tanabe Y, Kusano M, Okayasu T, Hosokawa M, Fujita M.
    Rinsho Byori; 1995 Mar; 43(3):238-46. PubMed ID: 7745829
    [Abstract] [Full Text] [Related]

  • 16. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma.
    Gao XS, Qiao XY, Yang XR, Asaumi J, Zhou ZG, Wang YD, Zhou DA, Wan J, Kuroda M, Kishi K, Kawasaki S, Hiraki Y.
    Oncol Rep; 2002 Mar; 9(4):767-72. PubMed ID: 12066206
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C.
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [Abstract] [Full Text] [Related]

  • 19. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K.
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [Abstract] [Full Text] [Related]

  • 20. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L, Modha K, Albaddawi E, Subramanian S.
    J Support Oncol; 2008 Jan; 6(7):305-6. PubMed ID: 18847072
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.